Table of contents
Volume 92, Issue 12
Published online 14 June 2005 (2097-2306)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Author Index |
Keyword Index
Minireview
Role of insulin-like growth factor 1 receptor signalling in cancer FREE
O Larsson, A Girnita and L Girnita
Br J Cancer 92: 2097-2101; advance online publication, May 24, 2005; doi:10.1038/sj.bjc.6602627
Clinical Studies
Mammographic density and the risk of breast cancer in Japanese women FREE
C Nagata, T Matsubara, H Fujita, Y Nagao, C Shibuya, Y Kashiki and H Shimizu
Br J Cancer 92: 2102-2106; doi:10.1038/sj.bjc.6602643
Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17) FREE
D P Dearnaley, S D Fossa, S B Kaye, M H Cullen, S J Harland, M P J Sokal, J D Graham, J T Roberts, G M Mead, M V Williams, P A Cook and S P Stenning for The MRC Testicular Tumour Working Party
Br J Cancer 92: 2107-2113; advance online publication, May 31, 2005; doi:10.1038/sj.bjc.6602624
p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis FREE
E Lopez-Crapez, F Bibeau, S Thézenas, M Ychou, J Simony-Lafontaine, A Thirion, D Azria, J Grenier and P Senesse
Br J Cancer 92: 2114-2121; doi:10.1038/sj.bjc.6602622
Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer FREE
M Moehler, A Eimermacher, J Siebler, T Höhler, A Wein, M Menges, D Flieger, T Junginger, T Geer, E Gracien, P R Galle and M Heike
Br J Cancer 92: 2122-2128; advance online publication, June 7, 2005; doi:10.1038/sj.bjc.6602649
Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial FREE
S Lorenzen, J Duyster, C Lersch, S von Delius, M Hennig, R Bredenkamp, C Peschel and F Lordick
Br J Cancer 92: 2129-2133; advance online publication, June 7, 2005; doi:10.1038/sj.bjc.6602645
Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer FREE
K Nakamura, T Yamaguchi, T Ishihara, A Kobayashi, H Tadenuma, K Sudo, H Kato and H Saisho
Br J Cancer 92: 2134-2139; advance online publication, June 7, 2005; doi:10.1038/sj.bjc.6602644
Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma FREE
J J Ord, E Streeter, A Jones, K Le Monnier, D Cranston, J Crew, S P Joel, M A Rogers, R E Banks, I S D Roberts and A L Harris
Br J Cancer 92: 2140-2147; advance online publication, May 31, 2005; doi:10.1038/sj.bjc.6602650
Specific inhibition of the endothelin A receptor with ZD4054: clinical and pre-clinical evidence FREE
C D Morris, A Rose, J Curwen, A M Hughes, D J Wilson and D J Webb
Br J Cancer 92: 2148-2152; doi:10.1038/sj.bjc.6602676
Translational Therapeutics
Restoration of plakoglobin expression in bladder carcinoma cell lines suppresses cell migration and tumorigenic potential FREE
K M Rieger-Christ, L Ng, R S Hanley, O Durrani, H Ma, A S Yee, J A Libertino and I C Summerhayes
Br J Cancer 92: 2153-2159; advance online publication, June 7, 2005; doi:10.1038/sj.bjc.6602651
Metallothionein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colon FREE
E T Donnelly, H Bardwell, G A Thomas, E D Williams, M Hoper, P Crowe, W G McCluggage, M Stevenson, D H Phillips, A Hewer, M R Osborne and F C Campbell
Br J Cancer 92: 2160-2165; advance online publication, May 31, 2005; doi:10.1038/sj.bjc.6602633
The use of Raman spectroscopy to differentiate between different prostatic adenocarcinoma cell lines FREE
P Crow, B Barrass, C Kendall, M Hart-Prieto, M Wright, R Persad and N Stone
Br J Cancer 92: 2166-2170; advance online publication, May 31, 2005; doi:10.1038/sj.bjc.6602638
Molecular Diagnostics
Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues FREE
A C P Riddick, C J Shukla, C J Pennington, R Bass, R K Nuttall, A Hogan, K K Sethia, V Ellis, A T Collins, N J Maitland, R Y Ball and D R Edwards
Br J Cancer 92: 2171-2180; advance online publication, May 31, 2005; doi:10.1038/sj.bjc.6602630
Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma FREE
K Hamana, K Uzawa, K Ogawara, M Shiiba, H Bukawa, H Yokoe and H Tanzawa
Br J Cancer 92: 2181-2184; advance online publication, May 31, 2005; doi:10.1038/sj.bjc.6602635
Bcl-2 expression predicts radiotherapy failure in laryngeal cancer FREE
P Nix, L Cawkwell, H Patmore, J Greenman and N Stafford
Br J Cancer 92: 2185-2189; advance online publication, May 31, 2005; doi:10.1038/sj.bjc.6602647
Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer FREE
W K Leung, K-F To, E S H Chu, M W Y Chan, A H C Bai, E K W Ng, F K L Chan and J J Y Sung
Br J Cancer 92: 2190-2194; advance online publication, June 7, 2005; doi:10.1038/sj.bjc.6602636
Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN) FREE
S Andersson, H Safari, M Mints, I Lewensohn- Fuchs, U Gyllensten and B Johansson
Br J Cancer 92: 2195-2200; advance online publication, June 7, 2005; doi:10.1038/sj.bjc.6602648
The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer FREE
M B Klevesath, L G Bobrow, S E Pinder and A D Purushotham
Br J Cancer 92: 2201-2205; advance online publication, June 7, 2005; doi:10.1038/sj.bjc.6602641
Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer FREE
K Milde-Langosch, A-M Bamberger, G Rieck, D Grund, G Hemminger, V Müller and T Löning
Br J Cancer 92: 2206-2215; advance online publication, May 31, 2005; doi:10.1038/sj.bjc.6602655
Decreased expression of haemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovory of its expression inhibits cell growth FREE
M Onda, J Akaishi, S Asaka, J Okamoto, S Miyamoto, K Mizutani, A Yoshida, K Ito and M Emi
Br J Cancer 92: 2216-2224; doi:10.1038/sj.bjc.6602634
Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients FREE
G Tonini, B Vincenzi, D Santini, S Scarpa, T Vasaturo, C Malacrino, R Coppola, P Magistrelli, D Borzomati, A Baldi, A Antinori, M Caricato, G Nuzzo and A Picciocchi
Br J Cancer 92: 2225-2232; advance online publication, May 31, 2005; doi:10.1038/sj.bjc.6602632
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation FREE
C Jung, R-S Kim, H Zhang, S-J Lee, H Sheng, P J Loehrer, T A Gardner, M-H Jeng and C Kao
Br J Cancer 92: 2233-2239; advance online publication, May 31, 2005; doi:10.1038/sj.bjc.6602631
Genetics and Genomics
Gene expression signatures for colorectal cancer microsatellite status and HNPCC FREE
M Kruhøffer, J L Jensen, P Laiho, L Dyrskjøt, R Salovaara, D Arango, K Birkenkamp-Demtroder, F B Sørensen, L L Christensen, L Buhl, J-P Mecklin, H Järvinen, T Thykjaer, F P Wikman, F Bech-Knudsen, M Juhola, N N Nupponen, S Laurberg, C L Andersen, L A Aaltonen and T F Ørntoft
Br J Cancer 92: 2240-2248; advance online publication, May 24, 2005; doi:10.1038/sj.bjc.6602621
Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays FREE
N J W de Wit, J Rijntjes, J H S Diepstra, T H van Kuppevelt, U H Weidle, D J Ruiter and G N P van Muijen
Br J Cancer 92: 2249-2261; advance online publication, May 17, 2005; doi:10.1038/sj.bjc.6602612
The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder FREE
S C Sak, J H Barrett, A B Paul, D T Bishop and A E Kiltie
Br J Cancer 92: 2262-2265; advance online publication, May 10, 2005; doi:10.1038/sj.bjc.6602616
Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma FREE
R M Gemmill, M Zhou, L Costa, C Korch, R M Bukowski and H A Drabkin
Br J Cancer 92: 2266-2277; doi:10.1038/sj.bjc.6602646
Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours FREE
C Marian, A Scope, K Laud, E Friedman, F Pavlotsky, E Yakobson, B Bressac-de Paillerets and E Azizi
Br J Cancer 92: 2278-2285; advance online publication, May 31, 2005; doi:10.1038/sj.bjc.6602629
The DNA mismatch repair gene hMSH2 is a potent coactivator of oestrogen receptor 
FREE
O Wada-Hiraike, T Yano, T Nei, Y Matsumoto, K Nagasaka, S Takizawa, H Oishi, T Arimoto, S Nakagawa, T Yasugi, S Kato and Y Taketani
Br J Cancer 92: 2286-2291; advance online publication, May 10, 2005; doi:10.1038/sj.bjc.6602614
Author Index
Author Index for Volume 92 FREE
Br J Cancer 92: 2292-2301; doi:10.1038/sj.bjc.6602669
Keyword Index
Keyword Index for Volume 92 FREE
Br J Cancer 92: 2302-2306; doi:10.1038/sj.bjc.6602670
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
